Effect of Monacolin K and CoQ10 Supplementation in Hypertensive and Hypercholesterolemic Subjects with Metabolic Syndrome
This study evaluated the effects of a combined supplementation of Monacolin K (10 mg/day) and Coenzyme Q10 (30 mg/day) over 8 weeks in 40 patients with metabolic syndrome characterized by hypertension and hypercholesterolemia. The intervention led to significant reductions in systolic and diastolic blood pressure, total cholesterol, LDL cholesterol, and
June 26, 2025
No Comments